CytoSorbents (CTSO) Stock Price, Quote, News & History | Benzinga

SPY764.04+0.01%QQQ703.98−0.07%BTC/USD81,187.43−3.38%DIA527.98+0.02%GLD368.57−0.12%TLT81.84+0.12%

CytoSorbents Corp (CTSO) Stock Price, Quote, News & History

CTSONASDAQ

Trade with Public

Trade with Public

$6.01

0.6612.34%

Last update: Oct 22, 9:21 AM

$5.35

N/A

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$5.36

Close

$6.01

Volume / Avg.

66.42K / 28.02K

Day Range

$5.36 - $6.96

52 Wk Range

2.84 - 18.00

Market Cap

$16.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

4.27%

Days to Cover

11.98

Recent Cytosorbents Corp News

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth

CytoSorbents is progressing with U.S. FDA and Health Canada reviews for its DrugSorb-ATR device.

Lekha Gupta

Why CytoSorbents (CTSO) Stock Is Trading Higher

CytoSorbents shares are trading higher by 20% during Tuesday's session. The company entered into a new $20 million credit facility with Avenue Capital Group.

Henry Khederian

Gold Moves Lower; US Crude Stocks Decline Last Week

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90. The S&P 500 also rose, gaining, 0.23% to 4,792.56.

Avi Kapoor

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-9.15M

Investing Cash Flow (TTM)

-275.00K

Financing Cash Flow (TTM)

2.48M

Free Cash Flow (TTM)

-9.58M

Capital Expenditure (TTM)

-436.00K

Net Change in Cash (TTM)

-6.94M

Analyst Trends and Forecast

0

0

0

0

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$41.87M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.45

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-108.41%

Earnings Yield % (FWD)

-16.82%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.24

Company Debt

Total Debt

$17.24M

LT Debt

$3.09M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$4.41M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-